Cargando…
A community pharmacist-led smoking cessation intervention using a smartphone app (PharmQuit): A randomized controlled trial
WHO supports the harnessing of mobile technologies to improve access to smoking cessation services. As such, this study evaluated the effectiveness of smoking cessation services provided by community pharmacists using PharmQuit compared with standard care. The study was a prospective, multicenter, r...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963551/ https://www.ncbi.nlm.nih.gov/pubmed/35349576 http://dx.doi.org/10.1371/journal.pone.0265483 |
_version_ | 1784678012506079232 |
---|---|
author | Asayut, Narong Olson, Phayom Sookaneknun Kanjanasilp, Juntip Thanarat, Preut Senkraigul, Bhattaraporn Sittisarn, Chuthathip Suksawat, Suratsawatee |
author_facet | Asayut, Narong Olson, Phayom Sookaneknun Kanjanasilp, Juntip Thanarat, Preut Senkraigul, Bhattaraporn Sittisarn, Chuthathip Suksawat, Suratsawatee |
author_sort | Asayut, Narong |
collection | PubMed |
description | WHO supports the harnessing of mobile technologies to improve access to smoking cessation services. As such, this study evaluated the effectiveness of smoking cessation services provided by community pharmacists using PharmQuit compared with standard care. The study was a prospective, multicenter, randomized controlled trial that included 156 participants who were 18 years or older and smoked at least one cigarette daily for a month, were ready to quit, willing to participate, and had a smartphone. The study was performed at seven community pharmacies in three provinces in Thailand. Participants were allocated to the intervention (n = 78) and control groups (n = 78). Both groups received the usual smoking cessation services with pharmacotherapy and counseling from community pharmacists for 6 months. The intervention group received PharmQuit as an additional service. Both groups were scheduled for follow-up visits on days 7, 14, 30, 60, 120, and 180. The primary outcome was continuous abstinence rate on day 180. The secondary outcomes included 7-day point abstinence rate, number of cigarettes smoked per day, exhaled carbon monoxide levels, adherence rate to the program, and satisfaction with PharmQuit. An analysis using the intent-to-treat principle was performed. Smoking cessation rates and the number of cigarettes smoked per day were significantly higher during the follow-up visits in both groups (p < 0.05). However, there were no statistically significant differences between the two groups. The adherence rate to the smoking cessation program was higher in the intervention group than in the control group (74 days vs. 60 days, p > 0.05). The results showed the benefits of the contribution of community pharmacists. Although the inclusion of PharmQuit did not yield better results than pharmacists’ counselling alone, it may help obtain better adherence to smoking cessation programs. Trial registration: Thai Clinical Trials Registry: TCTR20200925004 on September 25, 2020 –retrospectively registered, http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=6841. |
format | Online Article Text |
id | pubmed-8963551 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-89635512022-03-30 A community pharmacist-led smoking cessation intervention using a smartphone app (PharmQuit): A randomized controlled trial Asayut, Narong Olson, Phayom Sookaneknun Kanjanasilp, Juntip Thanarat, Preut Senkraigul, Bhattaraporn Sittisarn, Chuthathip Suksawat, Suratsawatee PLoS One Research Article WHO supports the harnessing of mobile technologies to improve access to smoking cessation services. As such, this study evaluated the effectiveness of smoking cessation services provided by community pharmacists using PharmQuit compared with standard care. The study was a prospective, multicenter, randomized controlled trial that included 156 participants who were 18 years or older and smoked at least one cigarette daily for a month, were ready to quit, willing to participate, and had a smartphone. The study was performed at seven community pharmacies in three provinces in Thailand. Participants were allocated to the intervention (n = 78) and control groups (n = 78). Both groups received the usual smoking cessation services with pharmacotherapy and counseling from community pharmacists for 6 months. The intervention group received PharmQuit as an additional service. Both groups were scheduled for follow-up visits on days 7, 14, 30, 60, 120, and 180. The primary outcome was continuous abstinence rate on day 180. The secondary outcomes included 7-day point abstinence rate, number of cigarettes smoked per day, exhaled carbon monoxide levels, adherence rate to the program, and satisfaction with PharmQuit. An analysis using the intent-to-treat principle was performed. Smoking cessation rates and the number of cigarettes smoked per day were significantly higher during the follow-up visits in both groups (p < 0.05). However, there were no statistically significant differences between the two groups. The adherence rate to the smoking cessation program was higher in the intervention group than in the control group (74 days vs. 60 days, p > 0.05). The results showed the benefits of the contribution of community pharmacists. Although the inclusion of PharmQuit did not yield better results than pharmacists’ counselling alone, it may help obtain better adherence to smoking cessation programs. Trial registration: Thai Clinical Trials Registry: TCTR20200925004 on September 25, 2020 –retrospectively registered, http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=6841. Public Library of Science 2022-03-29 /pmc/articles/PMC8963551/ /pubmed/35349576 http://dx.doi.org/10.1371/journal.pone.0265483 Text en © 2022 Asayut et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Asayut, Narong Olson, Phayom Sookaneknun Kanjanasilp, Juntip Thanarat, Preut Senkraigul, Bhattaraporn Sittisarn, Chuthathip Suksawat, Suratsawatee A community pharmacist-led smoking cessation intervention using a smartphone app (PharmQuit): A randomized controlled trial |
title | A community pharmacist-led smoking cessation intervention using a smartphone app (PharmQuit): A randomized controlled trial |
title_full | A community pharmacist-led smoking cessation intervention using a smartphone app (PharmQuit): A randomized controlled trial |
title_fullStr | A community pharmacist-led smoking cessation intervention using a smartphone app (PharmQuit): A randomized controlled trial |
title_full_unstemmed | A community pharmacist-led smoking cessation intervention using a smartphone app (PharmQuit): A randomized controlled trial |
title_short | A community pharmacist-led smoking cessation intervention using a smartphone app (PharmQuit): A randomized controlled trial |
title_sort | community pharmacist-led smoking cessation intervention using a smartphone app (pharmquit): a randomized controlled trial |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963551/ https://www.ncbi.nlm.nih.gov/pubmed/35349576 http://dx.doi.org/10.1371/journal.pone.0265483 |
work_keys_str_mv | AT asayutnarong acommunitypharmacistledsmokingcessationinterventionusingasmartphoneapppharmquitarandomizedcontrolledtrial AT olsonphayomsookaneknun acommunitypharmacistledsmokingcessationinterventionusingasmartphoneapppharmquitarandomizedcontrolledtrial AT kanjanasilpjuntip acommunitypharmacistledsmokingcessationinterventionusingasmartphoneapppharmquitarandomizedcontrolledtrial AT thanaratpreut acommunitypharmacistledsmokingcessationinterventionusingasmartphoneapppharmquitarandomizedcontrolledtrial AT senkraigulbhattaraporn acommunitypharmacistledsmokingcessationinterventionusingasmartphoneapppharmquitarandomizedcontrolledtrial AT sittisarnchuthathip acommunitypharmacistledsmokingcessationinterventionusingasmartphoneapppharmquitarandomizedcontrolledtrial AT suksawatsuratsawatee acommunitypharmacistledsmokingcessationinterventionusingasmartphoneapppharmquitarandomizedcontrolledtrial AT asayutnarong communitypharmacistledsmokingcessationinterventionusingasmartphoneapppharmquitarandomizedcontrolledtrial AT olsonphayomsookaneknun communitypharmacistledsmokingcessationinterventionusingasmartphoneapppharmquitarandomizedcontrolledtrial AT kanjanasilpjuntip communitypharmacistledsmokingcessationinterventionusingasmartphoneapppharmquitarandomizedcontrolledtrial AT thanaratpreut communitypharmacistledsmokingcessationinterventionusingasmartphoneapppharmquitarandomizedcontrolledtrial AT senkraigulbhattaraporn communitypharmacistledsmokingcessationinterventionusingasmartphoneapppharmquitarandomizedcontrolledtrial AT sittisarnchuthathip communitypharmacistledsmokingcessationinterventionusingasmartphoneapppharmquitarandomizedcontrolledtrial AT suksawatsuratsawatee communitypharmacistledsmokingcessationinterventionusingasmartphoneapppharmquitarandomizedcontrolledtrial |